223 related articles for article (PubMed ID: 804134)
1. Prevention of Rh hemolytic disease--ten years' clinical experience with Rh immune globulin.
Freda VJ; Gorman JG; Pollack W; Bowe E
N Engl J Med; 1975 May; 292(19):1014-6. PubMed ID: 804134
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the Center for Rh-negative Mothers. Hospital Paula Jaraquemada (3 years)].
Krug A; Bianchi R; Pérez N; Ilabaca G; Farías S; Rojas E
Rev Chil Obstet Ginecol; 1981; 46(4):206-14. PubMed ID: 6099901
[No Abstract] [Full Text] [Related]
3. Rh hemolytic disease of the newborn: its cause and prevention.
Pollack W
Prog Clin Biol Res; 1981; 70():185-302. PubMed ID: 6273932
[No Abstract] [Full Text] [Related]
4. Epidemiology of Rh hemolytic disease of the newborn, United States, 1960-1979.
Adams MM; Gustafson J
Prog Clin Biol Res; 1981; 70():213-7. PubMed ID: 6273934
[No Abstract] [Full Text] [Related]
5. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security.
Zavala C; Salamanca F
Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398
[TBL] [Abstract][Full Text] [Related]
6. Prevention of Rh hemolytic disease of the newborn.
Jennings ER; Dibbern HH; Hodell FH; Monroe CH; Peckham NH; Sullivan JF; Pollack W
Calif Med; 1969 Feb; 110(2):130-3. PubMed ID: 4181977
[TBL] [Abstract][Full Text] [Related]
7. [Comparative analysis of the effects to date of the prevention of Rh incompatibility].
Jedwabny A; Suchocki S; Bobrowska G
Acta Haematol Pol; 1988; 19(1-2):56-8. PubMed ID: 2853507
[No Abstract] [Full Text] [Related]
8. The future of Rh immune globulin.
Gorman JG
Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):422-6. PubMed ID: 5003518
[No Abstract] [Full Text] [Related]
9. Effectiveness of Rh prophylaxis.
Woodrow JC
Haematologia (Budap); 1974; 8(1-4):281-90. PubMed ID: 4218822
[No Abstract] [Full Text] [Related]
10. Rho (d) immune globulin (human).
Med Lett Drugs Ther; 1974 Jan; 16(1):3-4. PubMed ID: 4202567
[No Abstract] [Full Text] [Related]
11. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
Spasova K; Vŭlcheva B
Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
[No Abstract] [Full Text] [Related]
12. Rh isoimmunization, Manitoba, 1963-75.
Bowman JM; Chown B; Lewis M; Pollock J
Can Med Assoc J; 1977 Feb; 116(3):282-4. PubMed ID: 402178
[TBL] [Abstract][Full Text] [Related]
13. Sound boards. Rh immunoprophylaxis: is antepartum therapy desirable?
Nusbacher J; Bove JR
N Engl J Med; 1980 Oct; 303(16):935-7. PubMed ID: 6774249
[No Abstract] [Full Text] [Related]
14. [Immunological aspects of the prevention of hemolytic disease of the newborn].
Antonian AK
Zh Eksp Klin Med; 1973; 13(6):44-9. PubMed ID: 4215267
[No Abstract] [Full Text] [Related]
15. [Status of the prevention of the hemolytic disease of the newborn with gamma globulin in Switzerland].
de Muralt G; Stampfli K
Gynaecologia; 1969; 167(5):285-8. PubMed ID: 4184765
[No Abstract] [Full Text] [Related]
16. [Prevention of RH sensitization].
Sulović V
Nar Zdrav; 1976; 32(3-4):151-6. PubMed ID: 829449
[No Abstract] [Full Text] [Related]
17. [Our experience in the prevention of Rh immunization with immunoglobulin anti-D].
Coletta A; Belletti F; Cardona A; Cammarota M; De Ninno F; Pennino G; Toro L; Miceli G
Minerva Ginecol; 1974 Jul; 26(7):404-6. PubMed ID: 4213550
[No Abstract] [Full Text] [Related]
18. Prevention of rhesus immunization in Australia. The first seven years.
Davey MG
Med J Aust; 1975 Aug; 2(7):263-7. PubMed ID: 808697
[TBL] [Abstract][Full Text] [Related]
19. Current clinical concepts in hemolytic disease and blood group incompatibility.
Cherry SH
Prog Clin Biol Res; 1981; 70():205-12. PubMed ID: 6273933
[No Abstract] [Full Text] [Related]
20. Rh immune globulin after genetic amniocentesis: impact on pregnancy outcome.
Crane JP; Rohland B; Larson D
Am J Med Genet; 1984 Dec; 19(4):763-8. PubMed ID: 6097129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
